This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: National Health Research Institutes. Active years: 2012-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2016
Title: Innovations of Inventor Wen-Yu Su
Introduction
Wen-Yu Su is a notable inventor based in Miaoli, Taiwan. He has made significant contributions to the field of ophthalmology through his innovative patents. With a total of 2 patents, his work focuses on improving ocular treatments and solutions.
Latest Patents
One of his latest patents is related to gamma-polyglutamic acid-based intraocular irrigation solutions. This ophthalmic irrigating solution comprises gamma-polyglutamic acid (γ-PGA) and/or its salt in an effective amount to increase the viscosity of the solution. Additionally, it includes an ophthalmically acceptable aqueous vehicle for the γ-PGA. The patent also discloses a method for irrigating ocular tissues, which involves introducing the ophthalmic irrigating solution to the ocular tissues of a patient.
Another significant patent by Wen-Yu Su is for a cross-linked oxidated hyaluronic acid used as a vitreous substitute. This composition includes a polymer that consists of oxidated hyaluronic acid cross-linked by a dihydrazide. The resulting hydrogel is transparent, colorless, and transforms from a liquid state into a gel-matrix at 37°C, making it a valuable substitute for vitreous humor.
Career Highlights
Wen-Yu Su is affiliated with the National Health Research Institutes, where he continues to advance his research and innovations in ophthalmology. His work has the potential to greatly enhance the quality of care for patients requiring ocular treatments.
Collaborations
Wen-Yu Su collaborates with esteemed colleagues, including Feng-Huei Lin and Ko-Hua Chen, who contribute to his research endeavors.
Conclusion
Wen-Yu Su's innovative patents and contributions to ophthalmology demonstrate his commitment to improving patient care through advanced medical solutions. His work continues to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
